未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial
Ren, Yupeng; Li, Yuxuan; Cao, Mingbo; Tang, Yongchang; Yuan, Feng; Yang, Gaoyuan; He, Zhiwei; Shi, Zheng; Su, Xiaorui; Yao, Zhicheng; Deng, Meihai
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏